Raymond James Financial
LLY icon

Raymond James Financial’s Eli Lilly LLY Stock Holding History

Raymond James Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Sell
800
-900
-53% -$920K ﹤0.01% 4296
2026
Q1 		$1.44M Buy
1,700
+1,400
+467% +$1.42M ﹤0.01% 3601
2025
Q4 		$270K Buy
+300
New +$287K ﹤0.01% 4644

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial's LLY Position: Q2 2026 in Review

Raymond James Financial increased its Eli Lilly (LLY) stake by 5.4% in Q2 2026, buying an estimated $90.1M and bringing the position to 1,713,850 shares worth $2.06B. The position accounts for 0.56% of the portfolio, ranked #25.

Raymond James Financial first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Raymond James Financial held 1,713,850 shares of Eli Lilly worth $2.06B as of Q2 2026.
  • Raymond James Financial bought 88,195 Eli Lilly shares in Q2 2026, an estimated $90.1M.
  • Eli Lilly made up 0.56% of Raymond James Financial's portfolio in Q2 2026, its #25 holding.
  • Raymond James Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.